Tags : Prostate Cancer Research

Seed

Lucida Medical secures Seed investment led by XTX Ventures

Cambridge University spin-out Lucida Medical secures substantial funding to develop AI for cancer screening Cambridge, UK – 18 March 2021. Cambridge start-up Lucida Medical has raised significant seed capital from a group of investors led by XTX Ventures and Prostate Cancer Research. The multi-million-pound investment is a major advance towards Lucida Medical’s goal to disrupt […]Read More